Well put, and I agree that people have a tendency to procrastinate which can be detrimental to early treatment strategies.

> why has no other country done it?

Since early in the pandemic many front-line doctors have been successfully reducing hospitalization and death through early treatment with a multi-drug approach. Those are the doctors and researchers that authored the publications I cited in my previous comment, especially [1]. Those doctors had to treat patients early in the pandemic with a very little scientific literature and clinical trials to guide them, hence the world wide collaboration in putting together reasonable guidance based on existing medicine with established efficacy and safety profiles.

They continue to use these techniques - which are being further investigated for efficacy and safety in ongoing clinical trials - but with scarce media coverage compared to the vaccines.

So in many ways countries around the world have been doing it to some degree, but it hasn't been the primary strategy, as you point out. Why hasn't it been the primary strategy? Well that's a good question and tough to answer with any certainty. To speculate, I'd say that vaccines had a tremendous amount of funding and media attention poured into them, more so than any multi-drug therapy regime.

Sure, these early treatments have happened on a small scale; I've seen some of the papers. And don't get me wrong here; clearly we have to start with informal experiments and progress to small studies, to find promising treatments, before we expand their use. But there's still a world of difference between one doctor in one hospital cherry-picking the patients who happen to come in early and treating them successfully, versus basing one's entire public health strategy on early treatments. For one thing, if you do somehow convince people to come in early, you're going to have a lot more patients to treat. Not only do you have to make sure you have enough of the drugs and other supplies, but you have to have enough trained staff to administer them.

All that said, I would actually like to see someone try it. There are plenty of countries that have little expectation of receiving much vaccine supply this year anyway; they have little to lose. But it's no slam dunk; they face a daunting public education problem first, and then if they somehow solve that puzzle, they'll have to deal with the logistical difficulties.

Against all that, I think vaccines have more than just a marketing advantage. As long as they're reasonably safe and effective, they're a much more practical solution. Of course, what counts as "reasonably safe and effective" is debatable.